ICM
SCL icon

Invenomic Capital Management’s Stepan Co SCL Stock Holding History

Invenomic Capital Management’s Portfolio SCL Stock Details SCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-183,264
Closed -$8.68M – 178
2025
Q4 		$8.68M Buy
183,264
+2,547
+1% +$117K 0.4% 85
2025
Q3 		$8.62M Buy
+180,717
New +$9.38M 0.42% 76

Other funds holding SCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Invenomic Capital Management's SCL Position: Q1 2026 in Review

Invenomic Capital Management sold out of Stepan Co (SCL) in Q1 2026, closing a stake of 183,264 shares — an estimated $8.68M sold.

Invenomic Capital Management first reported a position in SCL in Q3 2025 and held it in 2 quarters. The position peaked at $8.68M in Q4 2025. 224 funds tracked by Wall St. Rank hold SCL as of Q1 2026.

  • Invenomic Capital Management reported no remaining Stepan Co position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 183,264 Stepan Co shares in Q1 2026, an estimated $8.68M.
  • Invenomic Capital Management first reported a position in Stepan Co in Q3 2025 and held it in 2 quarters.
  • Invenomic Capital Management's Stepan Co position peaked at $8.68M in Q4 2025.
  • 224 funds tracked by Wall St. Rank held Stepan Co as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.